A subgroup of patients with high tumor burden and/or risk factors, such as blastoid morphology, high Ki-67 index, and TP53 alterations, may require immediate intensive treatment because of the rapidly growing aggressive nature of the disease. This evidence concerns the gene TP53 and neoplasm.